All evaluated GLP-1 RAs led to a significant increase in nausea risk, with orforglipron showing the highest risk, followed by exenatide, tirzepatide, semaglutide, and liraglutide
In addition to the Lipotropics blend, Lipo-Mino also contains a mixture of B vitamins which further help to facilitate fat loss and increase energy
Predictors of response to dipeptidyl peptidase-4 inhibitors: Evidence from randomized clinical trials
Additionally, the effects of 6-thio-dG and its dimer on other cellular targets were not examined, leaving the potential for off-target interactions that could impact safety profiles
Marx, corresponding author
Although the event rate was low (4.6/1000 person-years for semaglutide, 7.9 for liraglutide and 1.0 for bupropion/naltrexone), there was a ninefold increased risk with GLP-1 receptor agonists overall